Alexandria Venture Investments
Alexandria Ventures is the corporate strategic venture platform described on the source page. Since 1996 it has made direct investments in life science and agrifoodtech companies, aiming to support development of new therapeutic modalities, platforms, and agrifood technologies. The platform emphasizes deal sourcing, market insight generation, partnership development with entrepreneurs and academic institutions, and alignment with the companys tenant ecosystem.
Industries
Nr. of Employees
small (1-50)
Alexandria Venture Investments
Services
Providing direct, corporate-backed investments and strategic partnerships with companies in life sciences and agrifood technology sectors.
Providing direct, corporate-backed investments and strategic partnerships with companies in life sciences and agrifood technology sectors.
Expertise Areas
- Venture capital investment in life sciences
- Agrifoodtech investment
- Industry trend analysis for life sciences
- Partnership development and ecosystem building
Key Technologies
- Innovative therapeutic modalities
- Platform technologies for drug development
- Agrifood technology
- Venture investment and portfolio management practices
News & Updates
Ranked #1 among corporate investors in biopharma by Silicon Valley Bank by new deal volume for six consecutive years.
Ranked among the top 5 most active U.S. investors in agrifoodtech by AgFunder by number of companies invested in for three consecutive years.
Reported on-balance-sheet unrealized gains of $506 million as of December 31, 2022.
Reported adjusted cost basis of $1.2 billion for the venture portfolio as of December 31, 2022.
Ranked #1 among corporate investors in biopharma by Silicon Valley Bank by new deal volume for six consecutive years.
Ranked among the top 5 most active U.S. investors in agrifoodtech by AgFunder by number of companies invested in for three consecutive years.
Reported on-balance-sheet unrealized gains of $506 million as of December 31, 2022.
Reported adjusted cost basis of $1.2 billion for the venture portfolio as of December 31, 2022.